Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4681 AL 4695

Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years

McGeer PL, Rogers J, McGeer EG.

J Alzheimers Dis. 2016 Oct 4;54(3):853-857. doi: 10.3233/JAD-160488.

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease

Brody M, Liu E, Di J, Lu M, Margolin RA, Werth JL, Booth K, Shadman A, Brashear HR, Novak G.

J Alzheimers Dis. 2016 Oct 18;54(4):1509-1519. doi: 10.3233/JAD-160369.

Towards Personalized Intervention for Alzheimer's Disease

Peng X, Xing P, Li X, Qian Y, Song F, Bai Z, Han G, Lei H.

Genomics Proteomics Bioinformatics. 2016 Oct;14(5):289-297. doi: 10.1016/j.gpb.2016.01.006. Epub 2016 Sep 28.

Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis

Kim BY, Lee SH, Graham PL, Angelucci F, Lucia A, Pareja-Galeano H, Leyhe T, Turana Y, Lee IR, Yoon JH, Shin JI.

Mol Neurobiol. 2017 Nov;54(9):7297-7311. doi: 10.1007/s12035-016-0192-9. Epub 2016 Nov 4.

Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease

Ruthirakuhan M, Herrmann N, Suridjan I, Abraham EH, Farber I, Lanctôt KL.

Expert Opin Pharmacother. 2016 Dec;17(18):2417-2429. doi: 10.1080/14656566.2016.1258060. Epub 2016 Nov 22.

Non human primate models for Alzheimer's disease-related research and drug discovery

Van Dam D, De Deyn PP.

Expert Opin Drug Discov. 2017 Feb;12(2):187-200. doi: 10.1080/17460441.2017.1271320. Epub 2016 Dec 25.

Serum Testosterone and Cognitive Function in Ageing Male: Updating the Evidence

Giagulli VA, Guastamacchia E, Licchelli B, Triggiani V.

Recent Pat Endocr Metab Immune Drug Discov. 2016;10(1):22-30. doi: 10.2174/1872214810999160603213743.

Donepezil improves gait performance in older adults with mild Alzheimer's disease: a phase II clinical trial

Montero-Odasso M, Muir-Hunter SW, Oteng-Amoako A, Gopaul K, Islam A, Borrie M, Wells J, Speechley M.

J Alzheimers Dis. 2015;43(1):193-9. doi: 10.3233/JAD-140759.

The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease

Bedse G, Romano A, Lavecchia AM, Cassano T, Gaetani S.

J Alzheimers Dis. 2015;43(4):1115-36. doi: 10.3233/JAD-141635.

Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer's disease: a translational overview

Heckman PR, Wouters C, Prickaerts J.

Curr Pharm Des. 2015;21(3):317-31. doi: 10.2174/1381612820666140826114601.

Update on the neuroprotective effect of estrogen receptor alpha against Alzheimer's disease

Lan YL, Zhao J, Li S.

J Alzheimers Dis. 2015;43(4):1137-48. doi: 10.3233/JAD-141875.

Neuropathology of depression in Alzheimer's disease: current knowledge and the potential for new treatments

Khundakar AA, Thomas AJ.

J Alzheimers Dis. 2015;44(1):27-41. doi: 10.3233/JAD-148003.

Biometals and their therapeutic implications in Alzheimer's disease

Ayton S, Lei P, Bush AI.

Neurotherapeutics. 2015 Jan;12(1):109-20. doi: 10.1007/s13311-014-0312-z.

Cerebral circulation: function and dysfunction in Alzheimer's disease

Hamel E.

J Cardiovasc Pharmacol. 2015 Apr;65(4):317-24. doi: 10.1097/FJC.0000000000000177.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias